{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:57:16Z","timestamp":1790294236684,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"United Hospital Medical Staff Education and Research Committee"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s40261-020-00911-9","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:03:18Z","timestamp":1586178198000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage: A Safety and Tolerability Study"],"prefix":"10.1007","volume":"40","clinical-trial-number":[{"clinical-trial-number":"nct03000283","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jesse J.","family":"Corry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Asaithambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif M.","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Lassig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily H.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjana","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Tipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"11","key":"911_CR1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","volume":"375","author":"AI Qureshi","year":"2016","unstructured":"Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033\u201343.","journal-title":"N Engl J Med"},{"issue":"20","key":"911_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","volume":"358","author":"SA Mayer","year":"2008","unstructured":"Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127\u201337.","journal-title":"N Engl J Med"},{"issue":"9890","key":"911_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","volume":"382","author":"AD Mendelow","year":"2013","unstructured":"Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397\u2013408.","journal-title":"Lancet"},{"issue":"10175","key":"911_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","volume":"393","author":"DF Hanley","year":"2019","unstructured":"Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175):1021\u201332.","journal-title":"Lancet"},{"issue":"24","key":"911_CR5","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1212\/WNL.0000000000000519","volume":"82","author":"DB Zahuranec","year":"2014","unstructured":"Zahuranec DB, Lisabeth LD, Sanchez BN, Smith MA, Brown DL, Garcia NM, et al. Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology. 2014;82(24):2180\u20136.","journal-title":"Neurology"},{"issue":"9","key":"911_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1161\/01.STR.27.9.1459","volume":"27","author":"TN Taylor","year":"1996","unstructured":"Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke. 1996;27(9):1459\u201366.","journal-title":"Stroke"},{"issue":"3","key":"911_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00003246-200103000-00031","volume":"29","author":"MN Diringer","year":"2001","unstructured":"Diringer MN, Edwards DF. Admission to a neurologic\/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29(3):635\u201340.","journal-title":"Crit Care Med"},{"issue":"4","key":"911_CR8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/STROKEAHA.116.014416","volume":"48","author":"TY Wu","year":"2017","unstructured":"Wu TY, Sharma G, Strbian D, Putaala J, Desmond PM, Tatlisumak T, et al. Natural history of perihematomal edema and impact on outcome after intracerebral hemorrhage. Stroke. 2017;48(4):873\u20139.","journal-title":"Stroke"},{"issue":"4","key":"911_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/CCM.0000000000001553","volume":"44","author":"S Urday","year":"2016","unstructured":"Urday S, Beslow LA, Dai F, Zhang F, Battey TW, Vashkevich A, et al. Rate of perihematomal edema expansion predicts outcome after intracerebral hemorrhage. Crit Care Med. 2016;44(4):790\u20137.","journal-title":"Crit Care Med"},{"issue":"2","key":"911_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12028-016-0321-3","volume":"26","author":"Z Grunwald","year":"2017","unstructured":"Grunwald Z, Beslow LA, Urday S, Vashkevich A, Ayres A, Greenberg SM, et al. Perihematomal edema expansion rates and patient outcomes in deep and lobar intracerebral hemorrhage. Neurocrit Care. 2017;26(2):205\u201312.","journal-title":"Neurocrit Care"},{"issue":"1","key":"911_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/phar.1169","volume":"33","author":"PE Marik","year":"2013","unstructured":"Marik PE, Rivera R. Therapeutic effect of conivaptan bolus dosing in hyponatremic neurosurgical patients. Pharmacotherapy. 2013;33(1):51\u20135.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"911_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12028-010-9366-x","volume":"14","author":"R Dhar","year":"2011","unstructured":"Dhar R, Murphy-Human T. A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury. Neurocrit Care. 2011;14(1):97\u2013102.","journal-title":"Neurocrit Care"},{"issue":"1","key":"911_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12028-009-9296-7","volume":"12","author":"KN Sheth","year":"2010","unstructured":"Sheth KN, Cushing TA, Wendell L, Lev MH, Romero JM, Schwab K, et al. Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care. 2010;12(1):30\u20134.","journal-title":"Neurocrit Care"},{"issue":"9","key":"911_CR14","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/STROKEAHA.114.007343","volume":"46","author":"AJ Webb","year":"2015","unstructured":"Webb AJ, Ullman NL, Morgan TC, Muschelli J, Kornbluth J, Awad IA, et al. Accuracy of the ABC\/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke. 2015;46(9):2470\u20136.","journal-title":"Stroke"},{"issue":"9","key":"911_CR15","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1097\/CCM.0b013e3181847853","volume":"36","author":"E Zeynalov","year":"2008","unstructured":"Zeynalov E, Chen CH, Froehner SC, Adams ME, Ottersen OP, Amiry-Moghaddam M, et al. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Crit Care Med. 2008;36(9):2634\u201340.","journal-title":"Crit Care Med"},{"issue":"5","key":"911_CR16","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s11033-008-9287-3","volume":"36","author":"Z Sun","year":"2009","unstructured":"Sun Z, Zhao Z, Zhao S, Sheng Y, Zhao Z, Gao C, et al. Recombinant hirudin treatment modulates aquaporin-4 and aquaporin-9 expression after intracerebral hemorrhage in vivo. Mol Biol Rep. 2009;36(5):1119\u201327.","journal-title":"Mol Biol Rep"},{"issue":"12","key":"911_CR17","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.STR.23.12.1767","volume":"23","author":"GA Rosenberg","year":"1992","unstructured":"Rosenberg GA, Scremin O, Estrada E, Kyner WT. Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats. Stroke. 1992;23(12):1767\u201373 (discussion 73\u201374).","journal-title":"Stroke"},{"issue":"12","key":"911_CR18","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1089\/neu.2008.0597","volume":"25","author":"R Trabold","year":"2008","unstructured":"Trabold R, Krieg S, Scholler K, Plesnila N. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice. J Neurotrauma. 2008;25(12):1459\u201365.","journal-title":"J Neurotrauma"},{"issue":"6","key":"911_CR19","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1210\/jc.2005-2287","volume":"91","author":"JK Ghali","year":"2006","unstructured":"Ghali JK, Koren MJ, Taylor JR, Brooks-Asplund E, Fan K, Long WA, et al. Efficacy and safety of oral conivaptan: a V1A\/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab. 2006;91(6):2145\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"911_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12028-010-9379-5","volume":"13","author":"AM Naidech","year":"2010","unstructured":"Naidech AM, Paparello J, Liebling SM, Bassin SL, Levasseur K, Alberts MJ, et al. Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care. 2010;13(1):57\u201361.","journal-title":"Neurocrit Care"},{"issue":"1","key":"911_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1365-2265.2007.03149.x","volume":"69","author":"JG Verbalis","year":"2008","unstructured":"Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study. Clin Endocrinol. 2008;69(1):159\u201368.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"911_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MAJ.0b013e31817b8148","volume":"337","author":"D Annane","year":"2009","unstructured":"Annane D, Decaux G, Smith N, Conivaptan Study G. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci. 2009;337(1):28\u201336.","journal-title":"Am J Med Sci"},{"issue":"6","key":"911_CR23","doi-asserted-by":"publisher","first-page":"745 e1","DOI":"10.1016\/j.jcrc.2012.03.003","volume":"27","author":"T Human","year":"2012","unstructured":"Human T, Onuoha A, Diringer M, Dhar R. Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury. J Crit Care. 2012;27(6):745 e1\u2013 e5.","journal-title":"J Crit Care."},{"issue":"14","key":"911_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12883-014-0213-0","volume":"18","author":"VS Hedna","year":"2014","unstructured":"Hedna VS, Bidari S, Gubernick D, Ansari S, Satriotomo I, Khan AA, et al. Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature. BMC Neurol. 2014;18(14):213.","journal-title":"BMC Neurol"},{"issue":"1","key":"911_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12028-008-9179-3","volume":"11","author":"T Murphy","year":"2009","unstructured":"Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care. 2009;11(1):14\u20139.","journal-title":"Neurocrit Care"},{"issue":"1","key":"911_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12028-008-9152-1","volume":"11","author":"WL Wright","year":"2009","unstructured":"Wright WL, Asbury WH, Gilmore JL, Samuels OB. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care. 2009;11(1):6\u201313.","journal-title":"Neurocrit Care"},{"issue":"3","key":"911_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/02841850802647039","volume":"50","author":"CW Wang","year":"2009","unstructured":"Wang CW, Juan CJ, Liu YJ, Hsu HH, Liu HS, Chen CY, et al. Volume-dependent overestimation of spontaneous intracerebral hematoma volume by the ABC\/2 formula. Acta Radiol. 2009;50(3):306\u201311.","journal-title":"Acta Radiol"},{"issue":"3","key":"911_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12028-008-9089-4","volume":"9","author":"WD Freeman","year":"2008","unstructured":"Freeman WD, Barrett KM, Bestic JM, Meschia JF, Broderick DF, Brott TG. Computer-assisted volumetric analysis compared with ABC\/2 method for assessing warfarin-related intracranial hemorrhage volumes. Neurocrit Care. 2008;9(3):307\u201312.","journal-title":"Neurocrit Care"},{"issue":"2","key":"911_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/STROKEAHA.117.016677","volume":"49","author":"MD Haley","year":"2018","unstructured":"Haley MD, Gregson BA, Mould WA, Hanley DF, Mendelow AD. Retrospective methods analysis of semiautomated intracerebral hemorrhage volume quantification from a selection of the STICH II Cohort (early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas). Stroke. 2018;49(2):325\u201332.","journal-title":"Stroke"},{"issue":"1","key":"911_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/STROKEAHA.113.003352","volume":"45","author":"KN Sheth","year":"2014","unstructured":"Sheth KN, Kimberly WT, Elm JJ, Kent TA, Mandava P, Yoo AJ, et al. Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke. 2014;45(1):281\u20133.","journal-title":"Stroke"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-020-00911-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:44:16Z","timestamp":1628603056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-020-00911-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1007\/s40261-020-00911-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"6 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported by a grant from the United Hospital Medical Staff Education and Research Committee to Dr. Jesse Corry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jesse J. Corry, Ganesh Asaithambi, Arif M. Shaik, Jeffrey P. Lassig, Emily H. Marino, Bridget M. Ho, Amy L. Castle, Nilanjana Banerji, and Megan E. Tipps declare that they have no conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee (Quorum, QR#32036\/1) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Quorum Review IRB (Protocol number NSJC-1601).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent to participate: All subjects signed informed consent forms after voluntarily agreeing to participate in the study. Consent for publication: As part of the informed consent for this study, all participants consented to the publication of their fully de-identified data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}